Zobrazeno 1 - 10
of 749
pro vyhledávání: '"hyperfractionated radiotherapy"'
Publikováno v:
Zhongguo linchuang yanjiu, Vol 37, Iss 1, Pp 34-38 (2024)
Objective: To explore the short-and long-term efficacy and toxic and side effects of hyperfractionated radiotherapy with different fractionated doses in patients with limited stage small cell lung cancer (SCLC). Methods: From August 2017 to August
Externí odkaz:
https://doaj.org/article/3b89fcf3ec2b4d34b175d120ad06ce12
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 15, Pp 841-853 (2023)
Jie Huang,1,* Wenqiang Zhu,1,* Qiangzhi Duan,2,* Chaomang Zhu,1 Xueling Shi,1 Hongyu Zhao,1 Peng Cai,1 Duojie Li1 1Department of Radiotherapy, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, 233000, People’s Repu
Externí odkaz:
https://doaj.org/article/10fa6990980b485cac1b08716bb1acc3
Autor:
Chihiro Sugimoto, Shuhei Teranishi, Tomoe Sawazumi, Satoshi Nagaoka, Hirokazu Nagayama, Wataru Segawa, Shuntaro Hiro, Yukihito Kajita, Chihiro Maeda, Sousuke Kubo, Kenichi Seki, Ken Tashiro, Nobuaki Kobayashi, Masaki Yamamoto, Makoto Kudo, Takeshi Kaneko
Publikováno v:
Thoracic Cancer, Vol 14, Iss 13, Pp 1212-1216 (2023)
Abstract Primary tracheal small‐cell carcinoma is rare, and is often treated using small‐cell lung cancer guidelines given that no standard treatment has been established for it. We report a patient in whom nodules appeared in the trachea and lef
Externí odkaz:
https://doaj.org/article/ac9ee676ec514e498f4091a1e8e47340
Autor:
XIONG Yudi, ZHANG Xue, ZOU Ning, MOU Jingjing, LI Benhui, CHEN Weidong, LIAO Lingxia, ZHANG Jiucheng
Publikováno v:
Zhongliu Fangzhi Yanjiu, Vol 49, Iss 10, Pp 1054-1058 (2022)
Objective To evaluate prospectively the side effects and tolerance of docetaxel with concurrent late-course hyperfractionated radiotherapy after breast-conserving surgery for stage T1-T2 breast cancer, and to assess the value of this treatment in sho
Externí odkaz:
https://doaj.org/article/359a9d07f5ad40fd914a80eb92575750
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D. V. Gogolin, I. A. Gulidov, K. E. Medvedeva, Y. A. Ragulin, Y. S. Mardinsky, I. N. Ivanova, L. V. Kursova, I. I. Kotuhov, A. Y. Buksha
Publikováno v:
Сибирский онкологический журнал, Vol 18, Iss 4, Pp 21-26 (2019)
The purpose of the study was to compare the efficacy and toxicity of hypofractionated versus hyperfractionated radiotherapy in patients with inoperable lung cancer.Material and Methods. Patients with inoperable lung cancer, who were treated between 2
Externí odkaz:
https://doaj.org/article/5472422c4e4b4d40ba11d27bce50f8b6
Autor:
, editor, , editor
Publikováno v:
MCQs for ENT : Preparation for the FRCS (ORL-HNS), 2019.
Externí odkaz:
https://doi.org/10.1093/oso/9780198792000.003.0008
Autor:
I. A. Gulidov, A. G. Zolotkov, Yu. S. Mardynsky, I. N. Ivanova, L. V. Kursova, D. V. Gogolin, Yu. A. Ragulin
Publikováno v:
Сибирский онкологический журнал, Vol 0, Iss 1, Pp 12-15 (2016)
The 5-year treatment outcomes of 69 patients with stage IIA–IIIA locally advanced small cell lung cancer have been presented. Accelerated hyperfractionated radiotherapy was administered in the uneven daily dose fractionation (single dose of 1 + 1,5
Externí odkaz:
https://doaj.org/article/5dc8559b8d90490183c6949f961ec475
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Keiichi Jingu, Rei Umezawa, Haruo Matsushita, Yu Suzuki, Takaya Yamamoto, Yojiro Ishikawa, Noriyoshi Takahashi, Kazuya Takeda
Publikováno v:
Radiation Oncology Journal
Purpose: Re-irradiation is a treatment option for recurrent esophageal cancer patients with a history of radiotherapy, but there is a risk of severe late adverse effects. This study focused on the efficacy and safety of re-irradiation using hyperfrac